ロード中...
JAK Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis
Myelofibrosis (MF) is a manifestation of several disorders of hematopoiesis collectively referred to as myeloproliferative neoplasms (MPN). Allogeneic hematopoietic stem cell transplantation (ASCT) is the only therapy with proven curative potential. However, most patients with MF are in the 6(th) or...
保存先:
| 出版年: | Biol Blood Marrow Transplant |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4465357/ https://ncbi.nlm.nih.gov/pubmed/24680977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.03.017 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|